---
category: news
title: "StockWatch: After $50M from Nvidia, Investors Bullish on Recursion"
excerpt: "The appetites of biotech investors for companies expanding in artificial intelligence show no signs of slowing any time soon, as reflected by the stock surge enjoyed by Recursion Pharmaceuticals after Nvidia invested $50 million in the AI-focused drug developer."
publishedDateTime: 2023-07-14T16:34:00Z
originalUrl: "https://www.genengnews.com/topics/artificial-intelligence/stockwatch-after-50m-from-nvidia-investors-bullish-on-recursion/"
webUrl: "https://www.genengnews.com/topics/artificial-intelligence/stockwatch-after-50m-from-nvidia-investors-bullish-on-recursion/"
type: article
quality: 4
heat: -1
published: false

provider:
  name: GEN
  domain: genengnews.com

topics:
  - Microsoft AI
  - AI

related:
  - title: "AI Drug Discovery Firm Recursion Surges Following $50 Million Nvidia Investment"
    excerpt: "The latest sign of investorsâ€™ unrelenting demand for all things artificial intelligence related: a record rally in drug discovery firm Recursion Pharmaceuticals Inc. following an investment from Nvidia Corp."
    publishedDateTime: 2023-07-12T15:20:00Z
    webUrl: "https://www.bloomberg.com/news/articles/2023-07-12/ai-drug-discovery-firm-recursion-rxrx-surges-after-nvidia-nvda-investment"
    type: article
    provider:
      name: Bloomberg L.P.
      domain: bloomberg.com
    quality: 63
    images:
      - url: "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i3nhawbzVYEY/v1/1200x800.jpg"
        width: 1200
        height: 800
        isCached: true
  - title: "Nvidia invests $50 mln in Recursion to train AI models for drug discovery"
    excerpt: "Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies said on Wednesday."
    publishedDateTime: 2023-07-12T11:31:00Z
    webUrl: "https://www.reuters.com/technology/nvidia-invests-50-mln-recursion-train-ai-models-drug-discovery-2023-07-12/"
    type: article
    provider:
      name: Reuters
      domain: reuters.com
    quality: 48
  - title: "Nvidia invests $50 million in Recursion to train AI models for drug discovery"
    excerpt: "Recursion will train AI models on Nvidia's cloud platform using its own biological and chemical datasets exceeding 23,000 terabytes. Nvidia could then license the AI models to biotech firms via BioNeMo,"
    publishedDateTime: 2023-07-12T15:31:00Z
    webUrl: "https://www.aol.com/news/nvidia-invests-50-million-recursion-123138547.html"
    type: article
    provider:
      name: AOL
      domain: aol.com
    quality: 36
    images:
      - url: "https://media.zenfs.com/en/aol_reuters_29/595ea578ee597c46f6549989f122d454"
        width: 800
        height: 533
        isCached: true
  - title: "AMD: Unlocking AI Potential At A Fraction Of Nvidia's Price"
    excerpt: "Advanced Micro Devices, Inc. is a viable alternative to Nvidia Corporation in the AI market and its valuation is more attractive than NVDA. Click for more on AMD."
    publishedDateTime: 2023-07-10T13:38:00Z
    webUrl: "https://seekingalpha.com/article/4616068-amd-unlocking-ai-potential-at-a-fraction-of-nvidias-price"
    type: article
    provider:
      name: Seeking Alpha
      domain: seekingalpha.com
    quality: 19
  - title: "NVIDIA and Run:ai Streamlines AI Application Deployment Across Multi-Cloud Environments"
    excerpt: "NVIDIA with Run:ai, will be providing a consistent, full-stack solution that allows developers to build and test their AI applications on GPU-powered on-premises or on-cloud instances."
    publishedDateTime: 2023-07-10T12:18:00Z
    webUrl: "https://analyticsindiamag.com/nvidia-and-runai-streamlines-ai-application-deployment-across-multi-cloud-environments/"
    type: article
    provider:
      name: Analytics India Magazine
      domain: analyticsindiamag.com
    quality: 11

secured: "ylCdwrTXoGD72lFA91FD5RRQTXTJN3PF61qq/xnRKKPzjefePFws/YAaZqT6zt/teTulIRmqlsnmohoT9r3yNlnif5/4uVzmzPVR2BIebCuwuJy19Ihv1K9mjhJDNASGGmGFZMsP3Vv3L8/Ph+l5oojBFYLkL+qY44D0PsVpIIRuRBQgRKGfYqO8SfelK4GMhYvIvrU6WSLfTuEKgPGmFH4l0rZvtPxNKKxsXItWxRKTmJdhEVW0IGoKeA1cTC/etSenMnqG0Q65xu6qil+cFvCMI4WoVmNHhv7N5i02Pnv5OxufOG2GwbGjiecz1Hj5MNdN9yxVQVK5B5beUAc4DIzQ+MKEu5Qwc+jebhysVSGnBiFcUzjnT1NsbNcKMRC9fKiWSwtBQp91tTaJoPHYSRacBLXl5miUBksPapPRySs11ox5HI+Z3GGMtRyqRfgyn9rAPp9gjeRRwoEqSXVxjA9z1Ac33I1tYYhqxIiB4OHibFW/EAuwu6LwEXTt12hs99nH27xUAyXCiZaR+yLC/g==;HcuHQyxQy2bDTQLQ9nWDtw=="
---

